{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:21:12Z","timestamp":1771917672266,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.maturitas.2010.01.009","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T04:36:11Z","timestamp":1266208571000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Testosterone and the aging male: To treat or not to treat?"],"prefix":"10.1016","volume":"66","author":[{"given":"Jerald","family":"Bain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2010.01.009_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","article-title":"The decline of androgen levels in elderly men and its clinical and therapeutic implications","volume":"26","author":"Kaufman","year":"2005","journal-title":"Endo Rev"},{"key":"10.1016\/j.maturitas.2010.01.009_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/oxfordjournals.aje.a009519","article-title":"Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men","volume":"147","author":"Ferrini","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib4","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2007-1431","article-title":"Update in andrology","volume":"92","author":"Handelsman","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib5","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/jc.2006-0357","article-title":"Effects of testosterone supplementation on skeletal muscle fibre hypertrophy and satellite cells in community-dwelling older man","volume":"91","author":"Sinha-Hikim","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long term testosterone gel (Androgel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","article-title":"Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T","volume":"90","author":"Page","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1359\/JBMR.040819","article-title":"Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats","volume":"19","author":"Tivesten","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2010.01.009_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00774-004-0586-z","article-title":"Effects of estradiol and dihydrotestosterone on osteoblast gene expression in osteopenic ovariectomized rats","volume":"23","author":"Davey","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib10","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archinte.166.13.1380","article-title":"Low testosterone levels and the risk of anemia in older men and women","volume":"166","author":"Ferruci","year":"2006","journal-title":"Arch Int Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000180959","article-title":"Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures","volume":"29","author":"Claustres","year":"1988","journal-title":"Horm Res"},{"key":"10.1016\/j.maturitas.2010.01.009_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2007-1692","article-title":"Effects of graded doses of testosterone on erythropoiesis in health young and older men","volume":"93","author":"Coviello","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib13","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1210\/jc.2002-020632","article-title":"Testosterone treatment enhances regional brain perfusion in hypogonadal men","volume":"88","author":"Azad","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib14","first-page":"3578","article-title":"Testosterone replacement therapy improves mood in hypogonadal men: a clinical research centre study","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1176\/appi.ajp.160.1.105","article-title":"Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial","volume":"160","author":"Pope","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.maturitas.2010.01.009_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/jcem.84.2.5495","article-title":"Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study","volume":"84","author":"Barrett-Connor","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0074-7742(08)60746-1","article-title":"Human cortical areas underlying the perception of optic flow: brain imaging studies","volume":"44","author":"Greenlee","year":"2000","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib18","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jc.2002-020419","article-title":"Longitudinal assessment of serum free testosterone concentrations predicts memory performance and cognitive status in elderly men","volume":"87","author":"Moffat","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/gerona\/60.3.385","article-title":"Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study","volume":"60","author":"Fonda","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.maturitas.2010.01.009_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0015-0282(16)47716-2","article-title":"The influence of androgens on insulin resistance","volume":"41","author":"Shoupe","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2010.01.009_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0026-0495(82)90166-4","article-title":"Reduction in high density lipoproteins by anabolic steriods (stanozolol) therapy for postmenopausal osteoporosis","volume":"31","author":"Taggert","year":"1984","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2010.01.009_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0002-8703(87)90552-7","article-title":"Sex, plasma lipoproteins and atherosclerosis: prevailing assumptions and outstanding questions","volume":"114","author":"Godsland","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.maturitas.2010.01.009_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-9-2-181","article-title":"Androgen abuse by athletes","volume":"9","author":"Wilson","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2010.01.009_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/jcem-68-5-971","article-title":"The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance","volume":"68","author":"Friedel","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0026-0495(90)90150-B","article-title":"High density lipoprotein is not decreased if aromatizable androgen is administered","volume":"39","author":"Friedel","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2010.01.009_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0026-0495(94)90202-X","article-title":"Decreased testosterone and dehydroepiandrosterone sulfate are associated with increased glucose and insulin concentrations in non-diabetic men","volume":"43","author":"Haffner","year":"1994","journal-title":"Metabolisn"},{"key":"10.1016\/j.maturitas.2010.01.009_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2010.01.009_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2164\/jandrol.106.000125","article-title":"Obesity and male reproductive potential","volume":"27","author":"Hammond","year":"2006","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib29","first-page":"1140","article-title":"Attenuated luteininzing hormone (LH) pulse amplitude but normal pulse frequency, and its relation to plasma androgens in hypogonadism of obese men","volume":"76","author":"Vermeulen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.juro.2006.06.003","article-title":"The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?","volume":"176","author":"Kaplan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","article-title":"Androgens, insulin resistance and vascular disease in men","volume":"63","author":"Kapoor","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib32","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type-2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib33","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2007-2177","article-title":"Low testosterone levels are common and associated with insulin resistance in men with diabetes","volume":"93","author":"Grossman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2164\/jandrol.108.006015","article-title":"The emerging link between hypogonadism and metabolic syndrome","volume":"30","author":"Guay","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib35","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/jc.2008-0054","article-title":"Inverse association of testosterone and the metabolic syndrome is consistent across race and ethnic groups","volume":"93","author":"Kupelian","year":"2008","journal-title":"J. Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib36","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.100.16.1690","article-title":"Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease","volume":"100","author":"Webb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2010.01.009_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.ATV.14.5.701","article-title":"The association of hypotestosteronemia with coronary artery disease in men","volume":"14","author":"Phillips","year":"1994","journal-title":"Arterioscl Throm"},{"key":"10.1016\/j.maturitas.2010.01.009_bib38","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/jc.2008-2416","article-title":"Lower testosterone levels predict incident stroke and transient ischemic attack in older men","volume":"94","author":"Yeap","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease","volume":"24","author":"Liu","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2010.01.009_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2164\/jandrol.108.007245","article-title":"The dark side of testosterone deficiency: III. Cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-4295(02)01677-1","article-title":"Critical evaluation of hormonal therapy for carcinoma of the prostate","volume":"60","author":"Chodak","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.maturitas.2010.01.009_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(01)00663-5","article-title":"Hypogonadism and androgen replacement therapy in elderly men","volume":"110","author":"Basaria","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2164\/jandrol.108.005454","article-title":"Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth","volume":"29","author":"Basaria","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib45","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib46","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib47","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"171","author":"Lu-Yao","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib48","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2010.01.009_bib49","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2007-2595","article-title":"Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis","volume":"93","author":"Shahani","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib50","first-page":"3469","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men\u2014a clinical research center study","volume":"81","author":"Brodsky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib51","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/jc.2006-0173","article-title":"Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men","volume":"91","author":"Fink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib52","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib53","first-page":"87","article-title":"Long-term effects of Testim 1% testosterone gel in hypogonadal men","volume":"7","author":"Dean","year":"2005","journal-title":"Rev Urol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2164\/jandrol.108.006007","article-title":"Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/CIA.S1417","article-title":"The many faces of testosterone","volume":"2","author":"Bain","year":"2007","journal-title":"Clin Int Aging"},{"key":"10.1016\/j.maturitas.2010.01.009_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type-2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2164\/jandrol.107.002774","article-title":"A dose\u2013response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate","volume":"29","author":"Saad","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2164\/jandrol.108.007005","article-title":"Fifty-two week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type-2 diabetes and subnormal plasma testosterone","volume":"30","author":"Heufelder","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.maturitas.2010.01.009_bib59","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","article-title":"Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study","volume":"102","author":"English","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2010.01.009_bib60","first-page":"293","article-title":"Studies on prostatic cancer. I: The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.maturitas.2010.01.009_bib61","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2006.06.034","article-title":"Testosterone and prostate cancer: an historical perspective on a modern myth","volume":"50","author":"Morgentaler","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.maturitas.2010.01.009_bib62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risk of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib63","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0ng per mililiter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib64","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.urology.2006.08.1058","article-title":"Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0\u03bcg\/mL or less","volume":"68","author":"Morgentaler","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.maturitas.2010.01.009_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"43","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.maturitas.2010.01.009_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00002512-200017060-00001","article-title":"Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy","volume":"17","author":"Slater","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2010.01.009_bib67","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial","volume":"296","author":"Marks","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2010.01.009_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJM197307122890205","volume":"289","author":"Shahida","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc06-0637","article-title":"Low testosterone and high C-reactive protein concentrations predict low hematocrit in type-2 diabetes","volume":"29","author":"Bhatia","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2010.01.009_bib70","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1210\/jc.2003-030236","article-title":"The short-term effects of high-dose testosterone on sleep, breathing and function in older men","volume":"88","author":"Liu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2010.01.009_bib71","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1743-6109.2007.00553.x","article-title":"Testosterone therapy and obstructive sleep apnea: is there a real connection?","volume":"4","author":"Hanafy","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.maturitas.2010.01.009_bib72","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A: Biol Sci Med Sci"},{"key":"10.1016\/j.maturitas.2010.01.009_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13685530802571100","article-title":"Anabolic decline in the aging male: a situation of unbalanced syncrinology","volume":"11","author":"Valenti","year":"2008","journal-title":"Aging Male"},{"key":"10.1016\/j.maturitas.2010.01.009_bib74","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2007.00488.x","article-title":"Canadian Society for the Study of the Aging Male: response to Health Canada's position paper on testosterone treatment","volume":"4","author":"Bain","year":"2007","journal-title":"J Sex Med"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512210000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512210000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:48:43Z","timestamp":1759913323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512210000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0378512210000125"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2010.01.009","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone and the aging male: To treat or not to treat?","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2010.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}